Financials
- Market Capitalization 956.93 M
- Employee 121
- Founded 2013
- CEO N/A
- Website www.solidbio.com
- Headquarter Delaware, United States
- FIGI BBG00JN4FXG8
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-3.75
ratio cours/chiffre d'affaires
-112.72
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2497 | PHAR Pharming Group N.V. - ADS, each representing 10 | 13.75 USD | +0.22% | -4.71% | +4.56% | +31.96% | 964.81 M USD | ||
| 2498 | LXRX Lexicon Pharmaceuticals, Inc. - Common Stock | 2.17 USD | -2.25% | -6.47% | +11.28% | +82.35% | 963.91 M USD | ||
| 2510 | DBVT DBV Technologies S.A. - American Depositary Shares | 15.98 USD | -3.09% | -0.44% | -9.62% | +53.21% | 946.15 M USD | ||
| 2524 | LBRX LB Pharmaceuticals Inc - Common Stock | 32.25 USD | -2.12% | -6.03% | +12.96% | +69.74% | 924.82 M USD |